14 Nov, EOD - Indian

SENSEX 77580.31 (-0.14)

Nifty 50 23532.7 (-0.11)

Nifty Bank 50179.55 (0.18)

Nifty IT 42390.85 (0.05)

Nifty Midcap 100 54043.1 (0.45)

Nifty Next 50 67408.65 (0.46)

Nifty Pharma 21752 (-0.26)

Nifty Smallcap 100 17601.05 (0.81)

14 Nov, EOD - Global

NIKKEI 225 38642.91 (0.28)

HANG SENG 19426.34 (-0.05)

S&P 5912 (-1.31)

Login/Signup
LOGIN HERE
Cancel

Bajaj Healthcare Ltd

You are Here : Home > Markets > CompanyInformation > Board Meeting
BSE Code : 539872 | NSE Symbol : BAJAJHCARE | ISIN : INE411U01027 | Industry : Pharmaceuticals |


Board Meeting
Announcement Date Date Of Meeting Purpose Detail
11-Nov-2024 14-Nov-2024 Quarterly Results Bajaj Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2024 inter alia to consider and approve unaudited financial results for the quarter ended 30th September 2024.
16-Sep-2024 19-Sep-2024 Preferential Issue Bajaj Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 19/09/2024 inter alia to consider and approve Allotment of Equity shares and Warrants Outcome of the Board Meeting held to allot equity shares and warrants on preferential basis (As Per BSE Announcement Dated on 19.09.2024)
08-Aug-2024 14-Aug-2024 Quarterly Results Bajaj Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2024 inter alia to consider and approve Unaudited financial results for June 2024 and ESOP
05-Jul-2024 10-Jul-2024 Preferential Issue Bajaj Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/07/2024 inter alia to consider and approve 1. Proposed fund raising 2. Increase in Authorised share capital of the Company 3. Alteration in the Articles of Association of the Compay 4. Any other business As mentioned in the outcome of the Board Meeting (As per BSE Announcement Dated on 10/07/2024) Revised outcome of Board Meeting held on 10th July, 2024 (As per BSE Announcement Dated on 15/07/2024)
16-May-2024 24-May-2024 Accounts Bajaj Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/05/2024 inter alia to consider and approve 1. Audited Financial Results for the quarter and year ended March 31 2024. 2. Recommend final dividend on equity shares if any for the financial year ended March 31 2024. Outcome of Board Meeting held on 24th May, 2024 (As Per BSE Announcement dated on 24.05.2024)
06-May-2024 06-May-2024 Change in Other Executives Appointment of Chief Financial Officer of the Company w.e.f. 6th May, 2024 as approved by the Board of Directors at its meeting held on 6th May, 2024 Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, ('Listing Regulations') this is to inform you that the Board of Directors of our Company at its meeting held today i.e. 6th May, 2024, has considered and approved the following: ? Appointment of Mr. Dayashankar Patel as the Chief Financial Officer and Key Managerial Personnel (KMP) of the Company, with effect from 6th May, 2024 as recommended by the Nomination and Remuneration Committee and based on the approval of the Audit Committee of the Company; ? Appointment of M/s. V J Shah & Co., Chartered Accountants, as Internal Auditor of the Company for the FY 2024-25; ? Appointment of V. J. Talati & Co., Cost Accountants, as Cost Auditor of the Company for the FY 2024-25; and ? Appointment of Mr. Haresh Sanghvi, Practicing Company Secretary, as Secretarial Auditor of the Company for the FY 2024-25 Read less.. Board Meeting outcome for: Appointment of CFO Appointment of Secretarial Auditor Appointment of Cost Auditor Appointment of Internal Auditor
03-Feb-2024 09-Feb-2024 Quarterly Results Bajaj Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/02/2024 inter alia to consider and approve Pursuant to Regulation 29 of Securities Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 this is to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Friday 9th February 2024 inter alia to: ? Consider and approve unaudited Financial Results for the quarter and nine months ended 31st December 2023 along with the Limited Review Report thereon; and ? Any other matter with the permission of the Chair. Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, ('Listing Regulations') this is to inform you that the Board of Directors of our Company at its meeting held today i.e. 9th February, 2024, has considered and approved the following: ?? Unaudited Standalone Financial Results of the Company for the quarter and nine months ended on 31st December, 2023 along with the Limited Review Report thereon; (enclosed); ?? Resignation of Mr. Rupesh Nikam (DIN: 07007815) from the position of Chief Financial Officer (CFO), Whole Time Director (WTD) and Key Managerial Personnel (KMP) of the Company; and ?? Appointment of Ms. Apurva Bandivadekar as Company Secretary and Compliance Officer, Key Managerial Personnel of the Company pursuant to Section 203 of the Companies Act, 2013, Regulation 6 of Listing Regulations Unaudited results for the quarter ended 31st December, 2023 Resignation of Mr. Rupesh Nikam from the position of CFO and WTD of the Company Appointment of Ms. Apurva Bandivadekar as Company Secretary and Compliance Officer of the Company (As Per BSE Announcement Dated on 09/02/2024)
03-Nov-2023 09-Nov-2023 Quarterly Results Bajaj Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/11/2023 inter alia to consider and approve Pursuant to Regulation 29 of Securities Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulation 2015 this is to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Thursday 9th November 2023 inter alia to: -Consider and approve unaudited Financial Result for the quarter/half year ended 30th September 2023. -Any other matter with the permission of the Chair. Unaudited Financial Result for the Quarter/Half year ended 30th September 2023 Outcome of Board Meeting Outcome of Board Meeting - Appointment of Chief Technical Officer. (As Per BSE Announcement dated on 09.11.2023)
07-Aug-2023 14-Aug-2023 Quarterly Results Bajaj Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2023 inter alia to consider and approve unaudited financial result for the quarter ended 30th June 2023 and any other matter with the permission of the Chair. Outcome of Board Meeting dated 14th August, 2023. Financial result for the quarter ended 30th June, 2023 (As Per BSE Announcement Dated on 14.08.2023)
28-Jun-2023 28-Jun-2023 Change in Auditors Appointment of Statutory Auditor Intimation under Regulation 30 of SEBI(LODR) Regulations, 2015 for Outcome of Board Meeting for sale /disposal of Undertaking/Unit(s).
14-Jun-2023 14-Jun-2023 Change in Directors This is to inform you that, the Board of Directors of the Company at their meeting held today i.e 14th June 2023, has approved the appointment of Mr. Sandeep Shah (DIN: 06402659) as a Non- Executive Independent Director (additional director) on the Board of Director of the Company.
24-May-2023 30-May-2023 Accounts Bajaj Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2023 inter alia to consider and approve Pursuant to Regulation 29 of Securities Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulation 2015 this is to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Tuesday 30th May 2023 inter alia to: -Consider and approve Audited Financial Result for the quarter and year ended March 31 2023. -Recommend final dividend on equity shares if any for the financial year ended March 31 2023. -Any other matter with the permission of the Chair. You are requested to take the same on record. Recommendation of Final Dividend Outcome of Board Meeting held on 30th May, 2023 & Submission of financial result and recommendation of Final Dividend (As Per BSE Announcement Dated on 30.05.2023)
06-Feb-2023 13-Feb-2023 Quarterly Results Bajaj Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2023 inter alia to consider and approve Pursuant to Regulation 29 of Securities Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulation 2015 this is to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Monday 13th February 2023 inter alia to: Consider and approve unaudited financial result for the quarter and nine months ended 31st December 2022. Any other matter with the permission of the Chair. You are requested to take the same on record. Outcome of Board Meeting & submission of Unaudited Financial Results for the quarter and nine months ended December 31, 2022 (As Per BSE Announcement dated on 13.02.2023)
03-Nov-2022 11-Nov-2022 Quarterly Results Bajaj Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/11/2022 inter alia to consider and approve Pursuant to Regulation 29 of Securities Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulation 2015 this is to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Friday 11th November 2022 inter alia to: -Consider and approve unaudited financial result for the quarter/half year ended 30th September 2022. -Any other matter with the permission of the Chair. You are requested to take the same on record. The Board of Directors at its Meeting held today has inter alia, considered and approved the following: -The un-audited Financial Statements for the quarter/half year ended September 30, 2022, as recommended by the Audit Committee; and Pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure requirements) Regulations, 2015, we enclose the following: (i) Unaudited Financial Results for the quarter/half year ended September 30, 2022 along with limited review report; The above information is also available on the Company's website at www.bajajhealth.com. This is for your information and records. (As Per BSE Announcement dated on 11.11.2022)
04-Aug-2022 12-Aug-2022 Quarterly Results Bajaj Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2022 inter alia to consider and approve Pursuant to Regulation 29 of Securities Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulation 2015 this is to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Friday 12th August 2022 inter alia to: - Consider and approve unaudited financial result for the quarter ended 30th June 2022. -Any other matter with the permission of the Chair. Outcome of Board Meeting & submission of Unaudited Financial Results for the quarter ended June 30, 2022 (As per BSE Announcement Dated on 12/08/2022) In term of Regulation 47 of SEBI (LODR) Regulation, 2015, we hereby enclose the News Paper Advertisement published on August 13, 2022 in Business Standard (all editions) and Mumbai Lakshadeep with respect to financial result for the Quarter ended June 30, 2022. (As Per BSE Announcement Dated on 13/08/2022)
1 2